Skip to main content

Table 3 Estimates of DNA sequence polymorphism and tests of neutrality for pvs48/45

From: Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45

Country

Total isolates

SV sites

PI sites

# Mutations

K

H

Hd ± SD

π ± SD

dN

dS

Reference

Mexico

15

0

2

2

0.441

2

0.221 ± 0.121

0.00033 ± 0.00033

0.00042

0.00000

This study

Honduras

12

3

2

5

1.128

4

0.445 ± 0.170

0.00123 ± 0.00094

0.00136

0.00077

This study

Colombia

60

3

4

7

1.929

9

0.841 ± 0.024

0.00188 ± 0.00073

0.00185

0.002

This study

Peru

24

1

2

3

0.372

3

0.218 ± 0.103

0.00034 ± 0.00046

0.00045

0.00000

This study

Brazil

13

2

1

3

0.59

4

0.526 ± 0.153

0.00058 ± 0.00062

0.00019

0.00194

This study

Latin America

124

3

5

8

1.228

11

0.610 ± 0.047

0.00168 ± 0.00087

0.00176

0.00151

This study

Myanmar

8

2

5

7

2.722

5

0.889 ± 0.071

0.00216 ± 0.00110

0.00282

0.0000

This study

Thailand

18

5

4

9

1.392

5

0.484 ± 0.138

0.00116 ± 0.00101

0.00103

0.00085

This study

South Korea

86

0

2

2

0.716

3

0.611 ± 0.026

0.00053 ± 0.00004

0.00069

0.00000

[17]

North Korea

46

2

7

9

1.987

5

0.0018 ± 0.042

0.00147 ± 0.00069

0.00029

0.00186

[18]

Worldwide

282

7

5

12

1.047

15

0.686 ± 0.00149

0.00173 ± 0.00149

0.00188

0.00149

This study

  1. SV singleton variable, PI parsimony informative, K average number of pair-wise differences, H number of haplotypes, Hd haplotype diversity, π observed average pair-wise nucleotide diversity, dN number of non-synonymous substitutions, dS number of synonymous substitutions